MTOR and breast carcinoma: In addition to affecting the expressions of some pro-angiogenic factors such as HIF-1α, eNOS, and MMP-2/9, 4-CF can also inhibit the survival of human umbilical vascular endothelial cells and breast cancer cells by inhibiting the PI3K/AKT/mTOR pathway.